Atlas Trials

Study Evaluating MYO-029 in Adult Muscular Dystrophy

Clinical trial NCT00104078 · COMPLETED

Trial details

NCT number
NCT00104078
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Becker Muscular DystrophyFacioscapulohumeral Muscular DystrophyLimb-Girdle Muscular Dystrophy
Start date
2005-02-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.